# Sempra: financial statements, quarterly

SRE · NYSE · CIK 1032208 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sre.md) · [Financials](/companies/sre/financials.md) · [Filings](/companies/sre/filings.md) · [Insiders](/companies/sre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,892](/filings/0001032208-24-000026.md) | [2,894](/filings/0001032208-24-000046.md) | [3,173 d](/filings/0001032208-26-000010.md) | [3,697](/filings/0001032208-25-000027.md) | [2,484](/filings/0001032208-25-000048.md) | [2,569](/filings/0001032208-25-000065.md) | [3,068 d](/filings/0001032208-26-000010.md) | [3,681](/filings/0001032208-26-000030.md) | [2,700](/filings/0001032208-25-000048.md) | [2,756](/filings/0001032208-25-000065.md) | [3,281 d](/filings/0001032208-26-000010.md) | [3,428](/filings/0001032208-26-000030.md) |
| Interest expense | $m | [317](/filings/0001032208-24-000026.md) | [312](/filings/0001032208-23-000057.md) | [314 d](/filings/0001032208-24-000007.md) | [305](/filings/0001032208-24-000015.md) | [311](/filings/0001032208-24-000026.md) | [328](/filings/0001032208-25-000065.md) | [105 d](/filings/0001032208-26-000010.md) | [433](/filings/0001032208-26-000030.md) | [359](/filings/0001032208-25-000048.md) | [403](/filings/0001032208-25-000065.md) | [337 d](/filings/0001032208-26-000010.md) | [382](/filings/0001032208-26-000030.md) |
| Income tax | $m | [175](/filings/0001032208-24-000026.md) | [(52.0)](/filings/0001032208-24-000046.md) | [(9.0) d](/filings/0001032208-26-000010.md) | [172](/filings/0001032208-25-000027.md) | [(130)](/filings/0001032208-25-000048.md) | [(105)](/filings/0001032208-25-000065.md) | [282 d](/filings/0001032208-26-000010.md) | [57.0](/filings/0001032208-26-000030.md) | [172](/filings/0001032208-25-000048.md) | [482](/filings/0001032208-25-000065.md) | [(10.0) d](/filings/0001032208-26-000010.md) | [65.0](/filings/0001032208-26-000030.md) |
| Net income | $m | [615](/filings/0001032208-24-000026.md) | [732](/filings/0001032208-24-000046.md) | [748 d](/filings/0001032208-26-000010.md) | [812](/filings/0001032208-25-000027.md) | [725](/filings/0001032208-25-000048.md) | [649](/filings/0001032208-25-000065.md) | [676 d](/filings/0001032208-26-000010.md) | [917](/filings/0001032208-26-000030.md) | [473](/filings/0001032208-25-000048.md) | [95.0](/filings/0001032208-25-000065.md) | [352 d](/filings/0001032208-26-000010.md) | [1,037](/filings/0001032208-26-000030.md) |
| Diluted EPS | $ per share | [0.95](/filings/0001032208-24-000026.md) | [1.14](/filings/0001032208-24-000046.md) | not reported | [1.26](/filings/0001032208-25-000027.md) | [1.12](/filings/0001032208-25-000048.md) | [1.00](/filings/0001032208-25-000065.md) | not reported | [1.39](/filings/0001032208-26-000030.md) | [0.71](/filings/0001032208-25-000048.md) | [0.12](/filings/0001032208-25-000065.md) | not reported | [1.58](/filings/0001032208-26-000030.md) |
| Basic EPS | $ per share | [0.96](/filings/0001032208-24-000026.md) | [1.14](/filings/0001032208-24-000046.md) | not reported | [1.27](/filings/0001032208-25-000027.md) | [1.13](/filings/0001032208-25-000048.md) | [1.01](/filings/0001032208-25-000065.md) | not reported | [1.39](/filings/0001032208-26-000030.md) | [0.71](/filings/0001032208-25-000048.md) | [0.12](/filings/0001032208-25-000065.md) | not reported | [1.59](/filings/0001032208-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0001032208-23-000043.md) | [1.1](/filings/0001032208-23-000057.md) | [0.2](/filings/0001032208-25-000012.md) | [0.6](/filings/0001032208-24-000015.md) | [0.2](/filings/0001032208-24-000026.md) | [0.6](/filings/0001032208-24-000046.md) | [1.6](/filings/0001032208-26-000010.md) | [1.7](/filings/0001032208-25-000027.md) | [0.2](/filings/0001032208-25-000048.md) | [0.0](/filings/0001032208-25-000065.md) | [0.0](/filings/0001032208-26-000030.md) | [0.8](/filings/0001032208-26-000030.md) |
| Current assets | $bn | [4.8](/filings/0001032208-23-000043.md) | [5.3](/filings/0001032208-23-000057.md) | [5.5](/filings/0001032208-25-000012.md) | [5.6](/filings/0001032208-24-000015.md) | [4.4](/filings/0001032208-24-000026.md) | [5.1](/filings/0001032208-24-000046.md) | [5.3](/filings/0001032208-26-000010.md) | [5.7](/filings/0001032208-25-000027.md) | [4.2](/filings/0001032208-25-000048.md) | [31.7](/filings/0001032208-25-000065.md) | [34.8](/filings/0001032208-26-000030.md) | [36.2](/filings/0001032208-26-000030.md) |
| Total assets | $bn | [82.7](/filings/0001032208-23-000043.md) | [85.7](/filings/0001032208-23-000057.md) | [87.2](/filings/0001032208-25-000012.md) | [89.6](/filings/0001032208-24-000015.md) | [90.5](/filings/0001032208-24-000026.md) | [93.7](/filings/0001032208-24-000046.md) | [96.2](/filings/0001032208-26-000010.md) | [99.0](/filings/0001032208-25-000027.md) | [99.9](/filings/0001032208-25-000048.md) | [107](/filings/0001032208-25-000065.md) | [111](/filings/0001032208-26-000030.md) | [114](/filings/0001032208-26-000030.md) |
| Current liabilities | $bn | [8.5](/filings/0001032208-23-000043.md) | [8.8](/filings/0001032208-23-000057.md) | [10.1](/filings/0001032208-25-000012.md) | [9.1](/filings/0001032208-24-000015.md) | [9.5](/filings/0001032208-24-000026.md) | [9.8](/filings/0001032208-24-000046.md) | [9.7](/filings/0001032208-26-000010.md) | [9.9](/filings/0001032208-25-000027.md) | [8.6](/filings/0001032208-25-000048.md) | [20.0](/filings/0001032208-25-000065.md) | [21.9](/filings/0001032208-26-000030.md) | [21.4](/filings/0001032208-26-000030.md) |
| Short-term borrowings | $bn | [2.5](/filings/0001032208-23-000043.md) | [2.0](/filings/0001032208-23-000057.md) | [2.3](/filings/0001032208-25-000012.md) | [1.7](/filings/0001032208-24-000015.md) | [2.2](/filings/0001032208-24-000026.md) | [2.2](/filings/0001032208-24-000046.md) | [2.0](/filings/0001032208-26-000010.md) | [2.1](/filings/0001032208-25-000027.md) | [2.3](/filings/0001032208-25-000048.md) | [1.8](/filings/0001032208-25-000065.md) | [4.2](/filings/0001032208-26-000030.md) | [3.7](/filings/0001032208-26-000030.md) |
| Shareholders' equity | $bn | [27.8](/filings/0001032208-23-000043.md) | [28.2](/filings/0001032208-23-000057.md) | [28.7](/filings/0001032208-25-000012.md) | [29.1](/filings/0001032208-24-000015.md) | [29.5](/filings/0001032208-24-000026.md) | [29.7](/filings/0001032208-24-000046.md) | [31.2](/filings/0001032208-26-000010.md) | [31.6](/filings/0001032208-25-000027.md) | [31.7](/filings/0001032208-25-000048.md) | [31.2](/filings/0001032208-25-000065.md) | [31.6](/filings/0001032208-26-000030.md) | [32.2](/filings/0001032208-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,757 d](/filings/0001032208-24-000026.md) | [1,392 d](/filings/0001032208-24-000046.md) | [1,089 d](/filings/0001032208-26-000010.md) | [1,851](/filings/0001032208-25-000027.md) | [669 d](/filings/0001032208-25-000048.md) | [1,022 d](/filings/0001032208-25-000065.md) | [1,365 d](/filings/0001032208-26-000010.md) | [1,482](/filings/0001032208-26-000030.md) | [784 d](/filings/0001032208-25-000048.md) | [1,110 d](/filings/0001032208-25-000065.md) | [1,189 d](/filings/0001032208-26-000010.md) | [1,809](/filings/0001032208-26-000030.md) |
| Capital expenditure | $m | [2,452 d](/filings/0001032208-23-000043.md) | [1,792 d](/filings/0001032208-23-000057.md) | [2,323 d](/filings/0001032208-26-000010.md) | [1,933](/filings/0001032208-25-000027.md) | [1,897 d](/filings/0001032208-25-000048.md) | [1,935 d](/filings/0001032208-25-000065.md) | [2,450 d](/filings/0001032208-26-000010.md) | [2,336](/filings/0001032208-26-000030.md) | [2,304 d](/filings/0001032208-25-000048.md) | [2,561 d](/filings/0001032208-25-000065.md) | [3,411 d](/filings/0001032208-26-000010.md) | [2,461](/filings/0001032208-26-000030.md) |
| Dividends paid | $m | [374 d](/filings/0001032208-24-000026.md) | [375 d](/filings/0001032208-24-000046.md) | [374 d](/filings/0001032208-26-000010.md) | [362](/filings/0001032208-25-000027.md) | [379 d](/filings/0001032208-25-000048.md) | [380 d](/filings/0001032208-25-000065.md) | [378 d](/filings/0001032208-26-000010.md) | [380](/filings/0001032208-26-000030.md) | [407 d](/filings/0001032208-25-000048.md) | [408 d](/filings/0001032208-25-000065.md) | [408 d](/filings/0001032208-26-000010.md) | [409](/filings/0001032208-26-000030.md) |
| Share repurchases | $m | [0.0 d](/filings/0001032208-24-000026.md) | [1.0 d](/filings/0001032208-24-000046.md) | [0.0 d](/filings/0001032208-26-000010.md) | [40.0](/filings/0001032208-25-000027.md) | [0.0 d](/filings/0001032208-25-000048.md) | [1.0 d](/filings/0001032208-25-000065.md) | [2.0 d](/filings/0001032208-26-000010.md) | [57.0](/filings/0001032208-26-000030.md) | [1.0 d](/filings/0001032208-25-000048.md) | [0.0 d](/filings/0001032208-25-000065.md) | [0.0 d](/filings/0001032208-26-000010.md) | [20.0](/filings/0001032208-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [316](/filings/0001032208-23-000043.md) | [632](/filings/0001032208-23-000057.md) | [632](/filings/0001032208-24-000015.md) | [632](/filings/0001032208-24-000026.md) | [632](/filings/0001032208-24-000046.md) | [635](/filings/0001032208-25-000027.md) | [636](/filings/0001032208-25-000048.md) | [638](/filings/0001032208-25-000065.md) | [653](/filings/0001032208-26-000030.md) | [653](/filings/0001032208-25-000048.md) | [654](/filings/0001032208-25-000065.md) | [655](/filings/0001032208-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 653,690,046 at 2026-05-04, from the cover of the [10-Q filed 2026-05-07](/filings/0001032208-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.